JANX JANUX THERAPEUTICS INC
FollowCOM (common), issuer CIK 1817713
Filings received so far for Q3 2026: 6 13F filers report a position in JANX shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| CONGRESS ASSET MANAGEMENT CO | 84,211 | $1.46M | 0.01% | +16,601 | 13F-HRTimeline |
| Versant Capital Management, Inc | 4,150 | $71.7K | 0.01% | +1,535 | 13F-HRTimeline |
| GAMMA Investing LLC | 1,642 | $28.4K | <0.01% | +661 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 209 | $3.61K | <0.01% | +46 | 13F-HRTimeline |
| Marquette Asset Management, LLC | 31 | $536 | <0.01% | new | 13F-HRTimeline |
| True Wealth Design, LLC | 5 | $87 | <0.01% | new | 13F-HRTimeline |